mcc-555 has been researched along with Insulin Resistance in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bailey, ST; Ishii, S; Krakow, SL; Lazar, MA; Minami, C; Reginato, MJ; Tanaka, H | 1 |
| Ishii, S; Kasayama, S; Kouhara, H; Kurebayashi, S; Shiraishi, M; Xu, X | 1 |
| Ishii, S; Tanaka, H; Upton, R; Widdowson, PS; Williams, G | 1 |
3 other study(ies) available for mcc-555 and Insulin Resistance
| Article | Year |
|---|---|
A potent antidiabetic thiazolidinedione with unique peroxisome proliferator-activated receptor gamma-activating properties.
Topics: 3T3 Cells; Adipocytes; Animals; Cell Differentiation; Gene Expression Regulation; Hypoglycemic Agents; Insulin Resistance; Male; Mice; Receptors, Cytoplasmic and Nuclear; Recombinant Fusion Proteins; Thiazoles; Thiazolidinediones; Transcription Factors | 1998 |
A novel thiazolidinedione MCC-555 down-regulates tumor necrosis factor-alpha-induced expression of vascular cell adhesion molecule-1 in vascular endothelial cells.
Topics: Aorta; Cell Adhesion; Down-Regulation; Endothelium, Vascular; Gene Expression; Humans; Hypoglycemic Agents; Insulin Resistance; NF-kappa B; PPAR alpha; PPAR gamma; Promoter Regions, Genetic; Thiazoles; Thiazolidinediones; Tumor Necrosis Factor-alpha; U937 Cells; Vascular Cell Adhesion Molecule-1 | 2005 |
Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
Topics: Animals; Basal Metabolism; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Fatty Acids; Hypoglycemic Agents; Insulin; Insulin Resistance; Liver Glycogen; Male; Obesity; Rats; Rats, Zucker; Thiazoles; Thiazolidinediones; Treatment Outcome; Triglycerides | 1998 |